Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1)
determine the efficacy of THC-free cannabidiol (CBD oil) in reducing the severity of
agitation among participants and 2) determine whether THC-free CBD oil can reduce the burden
on caregivers and increase the participants' quality of life.